drugset / Trial / NCT02262546
Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of the study is to assess that pramipexole does not prolong the QT interval more than placebo
Timeline
- Start
- 2007-05
- Primary completion
- 2007-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | — | — |
| Subject | Pramipexole | Unknown | 4.5 mg | — |
Indications
No indication recorded.